VOTIS
Financiado
Vascular Optical Tomographic Imaging System We help diabetics keep their feet
Epidemiological studies confirm a link between diabetes and increased PAD (Peripheral Arterial Diseases) prevalence, and
diabetes is associated with a two- to four-fold increase in PAD compared to non-diabetics. PAD impedes resolu...
Epidemiological studies confirm a link between diabetes and increased PAD (Peripheral Arterial Diseases) prevalence, and
diabetes is associated with a two- to four-fold increase in PAD compared to non-diabetics. PAD impedes resolution of small
surface wounds and is an important predictor of diabetic foot ulcers (DFUs). DFUs are a chronic complication of diabetes.
Recent studies suggest that diabetics have a 25% risk of developing a DFU over their lifetime, and when a person with PAD
develops a DFU, often the DFU will not heal. Therefore, the physician who examines a patient with diabetes and foot ulcer
should always assess the vascular status of lower limbs. Nevertheless, PAD detection and the assessment of its severity is
a clinical challenge in diabetic patients with foot disease, due to altered clinical presentation of PAD and limitations of the
diagnostic procedures: many methods analyse only the outer surface of the sk VOTIS utilises an innovative, non-invasive
and patented methodology to assess the physiological health of the lower limb even before tangible symptoms appear.
Time is tissue.VOTIS aims to promote necessary changes in the armamentarium for treating peripheral artery disease
(PAD), ischaemia and low perfusion rates in diabetics. These changes support detection and preventative healthcare and
will improve control over disease progression. This, in turn, will lengthen the path to necessary amputations and reduce
associated health consequences and their costs. Our business opportunity is very attractive, considering the growing
number of diabetics at risk for foot amputations as well as the limited ability of currently-available solutions to detect, locate,
and quantify the severity of peripheral artery disease (PAD). We plan to increase our understanding of international market
conditions and related risks. The current feasibility study will help us to deepen both our roll-out plan and our plan to scaleup
VOTIS
ver más
Duración del proyecto: 8 meses
Fecha Inicio: 2019-07-21
Fecha Fin: 2020-03-31
Fecha Fin: 2020-03-31
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2020-03-31
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
EIC-SMEInst-2018-2020:
SME instrument
Cerrada
hace 6 años
Presupuesto
El presupuesto total del proyecto asciende a
71K€
Líder del proyecto
VOTIS SUBDERMAL IMAGING TECHNOLOGIES LTD.
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5
254.69K€ |
Participante